Full-Time

Farm Business Consultant

Updated on 9/3/2026

Deadline 8/1/27
Genus

Genus

1,001-5,000 employees

Global animal genetics and breeding technology

No salary listed

Remote in UK

Remote

Must work from the UK and travel to farms, client meetings, and industry events.

Category
Consulting (1)
Required Skills
Microsoft Office
ISO 9001
Financial analysis
Data Analysis

Get referred to Genus

See people who can refer or advise you

Requirements
  • Strong communication and relationship-building skills.
  • Ability to understand client needs and influence key decision makers.
  • Genuine interest in farm business performance, technical improvement, and long-term sustainability.
  • Good organisational skills and ability to manage an independent workload in a field-based role.
  • Confidence using data, insight, and practical knowledge to support decision making.
  • Proactive approach to developing client relationships and identifying new opportunities.
  • Good digital skills, including confidence using Microsoft Office and other business systems.
  • Full UK driving licence and willingness to travel to farms, client meetings, and industry events.
Responsibilities
  • Build trusted, long-term relationships with farming clients.
  • Visit farms to understand business performance, technical challenges, and improvement opportunities.
  • Carry out technical and financial analysis to identify strengths, risks, and areas for improvement.
  • Use Promar and wider industry benchmarking data to provide clear, objective insight.
  • Deliver practical recommendations that support profitability, efficiency, sustainability, and resilience.
  • Support clients with nutrition, fertility, forage and soil management, livestock housing, farm infrastructure, environmental compliance, organic production, and diversification.
  • Help farmers review business performance, plan for the future, and make informed decisions.
  • Grow and develop a client base over time.
  • Work collaboratively with colleagues across Promar and the wider business.
  • Take part in team meetings, company events, agricultural shows, conferences, and industry networking opportunities.
Desired Qualifications
  • Experience in agriculture, farm consultancy, technical sales, nutrition, farm business management, or another client-facing agricultural role would be valuable.
  • An agricultural, agriscience, or business-related qualification would be beneficial.

Genus is a global animal-genetics company focused on improving cattle and pig performance through breeding and genetic technologies. It operates two main units, ABS Global for bovine genetics and PIC for porcine genetics, offering breeding animals, reproduction services, and gene-editing and next-generation breeding tools. Its products work by combining genetics, reproductive biology, and data-driven selection to produce healthier herds, higher-quality food, and more efficient production. Genus differentiates itself through its global scale (operations in 30 countries and distribution to over 50 markets), its specialized units for cattle and pigs, and its integration of science with practical farming solutions. Its goal is to sustainably nourish the world by improving animal health, food quality, and the resilience of the global food system, while delivering value to customers and upholding ethical, collaborative values.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Basingstoke, United Kingdom

Founded

1933

Get referred to Genus

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Genus said 14 July 2026 FY26 results should beat consensus and cut leverage.
  • The Chinese porcine joint venture delivered about £111 million cash in FY26.
  • ABS posted double-digit profit growth in FY26, helped by the Value Acceleration Programme.

What critics are saying

  • North American PIC volumes weakened in FY26 from customer disease challenges.
  • Genus still depends on further approvals before selling PRRS-resistant pigs in Canada.
  • If EU and U.S. adoption stalls, PRRS-resistant pigs stay a stranded platform.

What makes Genus unique

  • PIC’s PRRS-resistant pigs won Canada approval on 23 January 2026.
  • Genus monetizes elite genetics through recurring royalties, not commodity livestock sales.
  • ABS and PIC combine bovine and porcine genetics across 100-plus countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Parental Leave

Employee Stock Purchase Plan

Paid Holidays

Paid Vacation

Tuition Reimbursement

Flexible Work Hours

Company News

Associated Press
Jan 23rd, 2026
Canada approves PRRSV-resistant pigs for food and feed to cut farm losses and antibiotic use

Canada has approved genetically engineered pigs resistant to porcine reproductive and respiratory syndrome viruses for use in food and feed. Health Canada and the Canadian Food Inspection Agency completed independent safety assessments following applications from Genus PLC and PIC Canada, concluding the pigs are as safe and nutritious as conventional pork. The approval addresses PRRSV, one of the most devastating virus classes affecting farmed pigs, which causes severe symptoms including breathing problems, fever and stillborn piglets. There are currently no effective treatments available. Genus PLC's PRRSV-resistant pigs are already approved in the US, Brazil, Colombia and the Dominican Republic. However, the company will not sell these pigs in Canada until receiving regulatory authorisation in other key markets. Canada's swine industry generated over $6.3 billion in farm cash receipts in 2024.

TipRanks
Oct 21st, 2024
Genus plc CFO to Retire, Successor Search Underway

Genus plc, a global leader in animal genetics, has announced the upcoming retirement of its Chief Financial Officer, Alison Henriksen, who will leave her role in July 2025 after five years with the company.

PharmiWeb
Sep 7th, 2023
Genus Plc Preliminary Results For The Year Ended 30 June 2023

SOLID PERFORMANCE AND GOOD STRATEGIC PROGRESSWEBCAST AVAILABLE AT 7:01AM GMT, 2.01 ESTLONDON--(BUSINESS WIRE)--Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2023. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 EST.Commenting on the performance and outlook, Jorgen Kokke, Chief Executive Officer, said:“The Group achieved a strong operational performance despite ongoing challenging market conditions for producers in several important markets. Revenues grew in all regions and both PIC and ABS delivered profit growth. This also enabled us to deliver record adjusted EBITDA and good cashflow for the Group. Growth in R&D investments, primarily due to the strategically important gene editing work and expansion of PIC’s elite farms, as well as higher interest costs, resulted in adjusted profit before tax consistent with the prior year.“PIC’s performance was particularly impressive, achieving a record adjusted operating profit for the year

MarketWatch
Apr 3rd, 2023
Genus Names Jorgen Kokke as Chief Executive Officer Designate

Genus PLC said Monday that it has appointed Jorgen Kokke as chief executive officer designate, effective from May 2.

PharmiWeb
Sep 8th, 2022
Genus Plc Reports Preliminary Results For The Year Ended 30 June 2022

Continued Strategic Progress in Challenging Markets. Webcast Available at 7:01AM BST, 2.01 EDT